Mumbai, Jan. 29 -- Suven Life Sciences has allotted 44,77,612 equity shares on preferential basis up on conversion of equivalent number of convertible warrants. Consequently, the paid up equity share capital has increased to 23,19,51,819 equity shares of Re 1 each.

Published by HT Digital Content Services with permission from Capital Market....